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INTRODUCTION
T h e  p a t h o g e n e s i s  o f 
esophageal adenocarcinoma 
(EAC) and its precursor lesion 
Barrett’s esophagus (BE) is 
incompletely known. Since 
EAC is frequently detected at an 
advanced stage, the prognosis of 
patients with advanced EAC is 
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ABSTRACT
Background & Aims: Inflammation plays an important role in the development of esophageal adenocarcinoma 
and its metaplastic precursor lesion, Barrett’s esophagus. Toll-like receptor (TLR) 2 signalling and lysosomal 
function have been linked to inflammation-associated carcinogenesis. We examined the expression of TLR2 
in the esophagus and the effect of long-term TLR2 activation on morphological changes and expression of 
factors involved in lysosomal function in a Barrett’s esophagus epithelium cell line. 
Methods: TLR2 expression in normal squamous esophagus, reflux esophagitis, Barrett’s esophagus 
and esophageal adenocarcinoma biopsies was assessed with Q-RT-PCR, in situ hybridization and 
immunohistochemistry. Barrett’s esophagus epithelium cells (BAR-T) were incubated with acid and bile 
salts in the presence or absence of the TLR2 agonist Pam3CSK4 for a period up to 4 weeks. Morphological 
changes were assessed with electron microscopy, while Q-RT-PCR was used to determine the expression 
of lysosomal enzymes (Cathepsin B and C) and factors involved in endocytosis (LAMP-1 and M6PR) and 
autophagy (LC3 and Rab7). 
Results: TLR2 was expressed in normal squamous esophagus, reflux esophagitis, Barrett’s esophagus but was 
most prominent in esophageal adenocarcinoma. Long-term TLR2 activation in acid and bile salts exposed 
BAR-T cells resulted in more and larger lysosomes, more mitochondria and increased expression of LAMP-
1, M6PR, Cathepsin B and C when compared to BAR-T cells incubated with acid and bile salts but no TLR2 
agonist. Factors associated with autophagy (LC3 and Rab7) expression remained largely unchanged. 
Conclusion: Activation of TLR2 in acid and bile salts exposed Barrett epithelium cells resulted in an increased 
number of mitochondria and lysosomes and increased expression of lysosomal enzymes and factors involved 
in endocytosis. 
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still poor, with a 5-year overall survival rate of 10-20% [1, 2]. 
Barrett’s esophagus is a premalignant condition of the distal 
part of the esophagus in which normal squamous epithelium 
is replaced by columnar-lined epithelium with characteristic 
goblet cells [3]. Both chronic inflammation and ongoing 
exposure to an acid and bile containing gastroesophageal 
refluxate are considered to be important pathogenic factors 
in the development of BE and EAC [3-5]. Toll-like receptor 
(TLR) 2 signalling and lysosomal function have been linked 
to inflammation associated carcinogenesis [6-10]. 
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Reflux of acid and bile salts is known to induce apoptosis, 
in which lysosomal membrane disruption has previously 
been demonstrated to play a role [11]. In BE and upper 
gastrointestinal cancer, including EAC, altered lysosomal 
function and activity and expression of factors involved in the 
lysosomal pathway have been reported [6, 7, 9, 10]. Lysosomes 
are intracellular organelles that are known to be involved in 
processing waste products and are important regulators in 
intracellular homeostasis [12]. The lysosomal pathway consists 
of endocytosis, autophagy and lysosomal degradation, in which 
endocytosis related factors lysosomal-associated membrane 
protein-1 (LAMP-1) and mannose-6-phosphate receptor 
(M6PR), autophagy related factors, microtubule-associated 
protein 1A/1B-light chain 3 (LC3) and Rab7 and lysosomal 
enzymes such as Cathepsin B and C are involved [12-16]. In 
rapidly growing malignancies, effective lysosomal function 
plays a crucial role [16].
TLR2 is an innate immune receptor, which is activated by 
microbial products obtained from gram-positive bacteria. Upon 
activation, a complex pro-inflammatory signalling pathway is 
activated [18]. The lysosomal pathway is crucial in appropriate 
TLR2 signalling and, additionally, TLR2 has previously been 
found to be associated with lysosomal function [19]. 
Based on the literature, we hypothesized that TLR2 
activation plays a protective role in neoplastic progression 
in BE, in which the lysosomal pathway may be involved. 
Data regarding the expression and function of TLR2 in the 
esophagus, including the effect of activation of its signalling 
pathway on the lysosomal pathway is limited. Unraveling 
this may gain more insight in the pathogenesis of BE and 
EAC. We examined the expression of TLR2 in the esophagus. 
Accordingly, the effect of long-term TLR2 activation on 
morphological changes and the expression of factors involved 
in lysosomal function in BE epithelium cells exposed to acid 
and bile salts were studied. 
METHODS
Biopsy specimens
During routine upper endoscopy, tissue samples were 
obtained from patients with BE associated EAC, BE, reflux 
esophagitis (RE) and normal controls. Of the 10 EAC patients, 
8 were male, mean age 69 years (range 51-87), 2 were diagnosed 
with tumor stage I, 3 with stage II, 3 with stage III, and 2 
with stage IV and without prior treatment with radio- or 
chemotherapy. Of the 10 BE patients, 7 were male, mean age 
60 years (range 38-74), median BE segment length 3 cm (range 
3-8), without (prior) dysplastic changes or ablative therapy and 
all used proton pump inhibitors (PPIs). Of the 10 RE patients, 
5 were male, mean age 58 years (range 43-65), 6 used PPIs 
and 7 had grade A esophagitis according to the Los Angeles 
criteria, 2 grade B, and 1 grade D. Of the 10 normal controls, 
6 were male, mean age 49 years (range 23-68) and all without 
reflux symptoms, PPI-use or endoscopic abnormalities. Paired 
biopsies were collected from EAC, BE and normal squamous 
esophagus (SQ) tissue ≥3 cm above the gastro-esophageal 
junction. The RE biopsies were taken next to the erosions. 
Duodenum biopsies were collected from BE patients as a 
positive control for intestinal type of epithelium. 
To study TLR2 expression at the mRNA and protein level, 
one biopsy was snap frozen in liquid nitrogen and stored at 
-80oC for subsequent RNA isolation and one biopsy was fixed 
in formalin and embedded in paraffin for histopathological 
evaluation, immunohistochemistry (IHC) and in situ 
hybridization (ISH). The Medical Ethical Committee of the 
University Medical Center Utrecht approved the study on 
September 30, 2009 and all patients signed informed consent. 
Cell culture 
The human telomerase-immortalized non-neoplastic 
Barrett epithelium cell line BAR-T was kindly provided by Dr. 
R.F. Souza and grown in a special supplemented keratinocyte 
basal medium-2 (Lonza, Breda, The Netherlands) according to 
Jaiswal et al. [21, 22]. The human embryonic kidney cell line 
HEK293 does not express TLR2 and was accordingly used as 
a negative control and cultured as described previously [22].
Short-term TLR2 stimulation
To evaluate the effect of TLR2 activation, BAR-T in HEK293 
cells were incubated for 24 hours with the synthetic TLR2 
agonist Pam3CSK4 (Invitrogen, San Diego, CA, USA) [23] at 
concentrations of 12.5, 25, 50 and 100 ng/ml. Incubation with 
20 ng/ml recombinant human tumor necrosis factor alpha 
(TNFα R&D Systems Europe Ltd, Oxon, UK) was included as a 
positive control for NF-κB activation. Supernatant was collected 
and total RNA was isolated, in order to determine TLR2 and 
interleukin 8 (IL8) mRNA expression and IL8 secretion. 
Experiments were performed three times in duplicate.
Long-term TLR2 stimulation combined with acid and 
bile salts
BAR-T cells were incubated for 4 weeks with acid and 
bile salts with or without the TLR2 agonist, to determine the 
effect of long-term TLR2 activation on morphological changes 
in BE cells exposed to acid and bile salts. Four experimental 
conditions were included: blanc, TLR2 agonist, acid and bile 
salts and TLR2 agonist combined with acid and bile salts. Two 
concurrent experiments were performed in duplicate. In T25 
cell culture flasks, 1.7 x 10^5 BAR-T cells were cultured in 
supplemented keratinocyte basal medium-2 with or without 
12.5 ng/ml of the TLR2 agonist Pam3CSK4. The appropriate 
BAR-T samples were 4 times per week exposed to a 200 µM 
bile salts mixture composed of 25% deoxycholic acid (DCA), 
45% glycocholic acid (GCA) and 30% taurochenodeoxycholic 
acid (TCDCA) at pH 4 for 5 minutes (Fig. 1). This acid and 
bile salts mixture was chosen based on previous studies and 
were optimized in cell culture experiments (data available 
upon request) [24-26]. Subsequently, samples were washed and 
culture medium with or without the TLR2 agonist was added. 
Cells were subcultured weekly. After 3 weeks, BAR-T samples 
were duplicated during subculturing; one sample was used for 
mRNA isolation and the other sample for electron microscopy 
(EM) at the end of the cell culture experiment at 4 weeks and 
culture medium of all samples was collected for enzyme linked 
immuno-sorbent assay (ELISA). 
Quantitative reverse transcriptase polymerase chain 
reaction (Q-RT-PCR)
Total RNA isolation from biopsies and BAR-T cells, 
measurement of RNA concentrations, confirmation of RNA 
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integrity, cDNA synthesis and Q-RT-PCR reactions were 
performed as previously described [22]. The primers (Table 
I) were mRNA specific to prevent signal information from 
contaminating genomic DNA. Using Taqman probes, LC3 
(Hs01076567_g1) and 2 endogenous reference genes were 
measured, i.e. GAPDH (Hs 4333764F) and β-2-microglobulin 
(Hs 4333766F) (Applied Biosystems, Foster City, CA, USA). All 
cDNA samples were analyzed in duplicate. The amplification 
results of the genes of interest were normalized to the mean 
value of corresponding GAPDH and β-2-microglobulin results 
using the ∆Ct method [27]. Data were expressed relative to 
the mean ∆Ct of SQ biopsies, to the control BAR-T cells not 
incubated with the TLR2 agonist (short-term cell culture 
experiment) or to the BAR-T cells incubated with acid and 
bile salts (long-term cell culture experiment), whenever 
appropriate.
TLR2 in situ hybridization (ISH)
TLR2 ISH was performed on 6 µm paraffin-embedded 
EAC, BE, SQ, RE and duodenum tissue sections as previously 
described [22]. A fluorescein labeled human TLR2 specific 
locked nucleic acid (LNA) and 2’-O-methyl-RNA (2OME) 
probe (5’-TagCucTguAgaTcuGaaG- 3’, with LNA residues in 
upper case and 2OME in lower case; 100uM 1:100 Ribotask 
ApS, Odense, Denmark) was used. The final signal was 
visualized using the VECTOR Blue AP Substrate Kit (Vector 
Laboratories, Burlingame, CA, USA); no counterstain was 
applied. Control slides in which the TLR2 probe was omitted 
were included (data not shown). 
TLR2 immunohistochemistry (IHC)
TLR2 IHC was performed as previously described, with 
subsequent incubation of polyclonal goat anti-human TLR2 
1:600 (Abcam, Cambridge, UK), biotinylated horse anti-goat, 
streptavidin-biotinylated horse radish peroxidase (Dako, 
Glostrup, Denmark), NovaRed as a chromogen substrate and 
haematoxylin as a counterstain (Vector Laboratories) [22]. 
No staining was observed in negative control slides in which 
the TLR2 antibody was omitted (data available on request). In 
control immunofluorescence experiments, the specificity of the 
TLR2 antibody was evaluated. TLR2 expression was absent in 
the negative control cells HEK293, whereas strong expression 
was observed in EAC cells (OE33; data available on request). 
Enzyme linked immunosorbent assay (ELISA)
Upon short-term (24 hours) and long-term (4 weeks) 
incubation with the TLR2 agonist, Pam3CSK4, we measured 
IL8 concentrations in the cell culture supernatant by ELISA 
(BD OptEIA™, San Diego, CA, USA). Absorbance was read 
at 450 nm on a spectrophotometric plate reader using the 
Microplate manager 5.2 software program (BioRad). All 
experiments were performed in duplicate and the average of 
two readings was calculated. 
Electron microscopy (EM) 
After 4 weeks of incubation of BAR-T cells with the 
TLR2 agonist Pam3CSK4, and acid and bile salts, a chemical 
fixative (2% formaldehyde, 2.5% glutaraldehyde in 0.1 M 
Na-cacodylate buffer, pH 7.4) was added to the culture flasks 
Fig. 1. Long-term incubation of BE epithelium cells with TLR2 agonist Pam3CSK4 and acid and 
bile salts. Time line of the stimulation of BAR-T cells with the TLR2 agonist Pam3CSK4, acid 
and bile salts for 4 weeks. BAR-T cells were cultured with or without 12.5 ng/ml Pam3CSK4. On 
Wednesday BAR-T cells were subcultured. The appropriate samples were incubated for 5 minutes 
with acid and bile salts mixture (200 µM; 25% DCA, 45% GCA and 30% TCDCA at pH 4) on 
Thursday, Friday, Monday and Tuesday. 
Table I. Primer sequences used for Q-RT-PCR with corresponding annealing temperature.
Target Forward primer Reverse primer Annealing T (30 sec)
TLR2 TTTCACTGCTTTCAACTGGTA TGGAGAGGCTGATGATGAC 57°C
IL8 CACCGGAAGGAACCATCTCACT TGCACCTTCACACAGAGCTGC 62°C
Cathepsin B AGTGGAGAATGGCACACCCTA AAGAAGCCATTGTCACCCCA 58°C
Cathepsin C CGGCTTCCTGGTAATTCTTC GTGGTCCCATAACCGAGCAG 58°C
LAMP-1 AACTTCTCTGCTGCCTTCTC GAGTGAGTGTATGTCCTCTTCC 58°C
M6PR AATCGACACACCCTAGCGGACAAT CAGCAACCAGTGATGCAAACGTGA 60°C
Rab7 AGTTCCCTGGAACCAGAACTTGGA TGTGACTAGCCTGTCATCCACCAT 58°C
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for 2 hours at room temperature to preserve the cellular 
morphology. Subsequently, the fixative was replaced by 0.1M 
Na-cacodylate buffer, pH 7.4. The cells were removed from 
the culture flask using a cell scraper and transferred to an 
Eppendorf vial (Eppendorf, Nijmegen, The Netherlands). After 
mild centrifugation, the supernatant was removed and the cells 
were resuspended in 1% agarose LM-MP (Roche, Woerden, 
the Netherlands) at 37°C. After centrifugation the agarose was 
solidified on ice and the cell pellet was cut into 1 mm3 blocks. 
Then cells were postfixed with 1% OsO4 and 1.5% K3Fe(CN)6 
in 0.065 M Na-cacodylate for 2 hours at 4°C. After dehydration 
with ethanol the blocks were embedded in EPON according 
to standard procedures. Ultrathin sections (50-70 nm) were 
prepared on a Leica Ultracut S (Leica, Vienna, Austria) and 
stained with uranylacetate and lead citrate using the Leica 
AC20  (Leica, Vienna, Austria). Fifteen random micrographs 
per experimental condition were taken on a Tecnai 12 (FEI, 
Eindhoven, The Netherlands) equipped with a SIS Megaview 
III. A mean of 2 cells were visible on a micrograph.  The volume 
densities of different organelles were blindly measured (R.V.) 
and revised by an independent experienced observer (G.P.) 
with point-hit using a simple square lattice test system in Image 
J (NIH, Bethesda, MD, USA) with a grid plugin (d=0.8µm; Fig. 
4c) [28]. The same lattice was used to measure intersections 
with membranes to evaluate the length density of membranes. 
Fig. 2. TLR2 mRNA and protein expression in esophageal biopsies. a) 
Q-RT-PCR showed that TLR2 mRNA expression was significantly increased 
in EAC compared to SQ biopsies. In BE and RE biopsies TLR2 expression 
was not significantly different compared to SQ. TLR2 expression in BE was 
not significantly different compared to duodenum. Number of patients: 
10 per subgroup.  Experiments were performed in duplicate. GAPDH and 
β-2-microglobulin were used for normalization. Data are expressed as 
mean±SEM, relative to the mean ∆Ct of SQ biopsies. Two-tailed t tests were 
used; * p<0.05. b) ISH showed evident expression of TLR2 mRNA in nuclei 
and in cytoplasm in SQ, RE, BE and EAC biopsies. TLR2 expression was 
seen in superficial epithelial cells, deeper crypts and lamina propria cells. 
Expression in duodenum corresponded to BE. No counterstain was used. 
c) IHC showed predominant expression of TLR2 in the basal keratinocytes 
in SQ, whereas in RE TLR2 expression reached up to the more superficial 
layer of the squamous epithelium. In BE, TLR2 expression was most 
prominent in superficial epithelial cells and deeper crypts, but also observed 
in lamina propria cells. In EAC, diffuse expression throughout the biopsy 
was observed. Haematoxylin counterstain was used. ISH and IHC pictures 
are representative for all cases. Number of patients: 10 per subgroup. 
Statistical analysis
IL8 secretion (ELISA) and all mRNA expression data were 
presented as mean ± standard error of the mean (SEM). Data 
were compared between the two groups of cell line samples and 
biopsies using two-tailed t tests and between multiple groups 
using ANOVA. A level of p<0.05 was considered statistically 
significant. SPSS software version 15.0 for Windows (SPSS Inc, 
Chicago, IL, USA) and GraphPad Prism version 5.0 (GraphPad 
Software, San Diego, CA, USA) were used for the statistical 
analyses.
RESULTS
TLR2 expression in the esophagus
TLR2 mRNA expression was examined in human 
esophageal biopsies using Q-RT-PCR. TLR2 expression 
was 3.6-fold increased in EAC (3.62±0.91) compared to SQ 
(1.00±0.09, p=0.02; Fig. 2a). TLR2 mRNA expression was 
2.09±0.66 (p=0.09) fold increased in BE and 1.47±0.38 (p=0.2) 
fold in RE compared to SQ. TLR2 mRNA expression was most 
evident in nuclei, but also in cytoplasm and in both epithelium 
and lamina propria cells (Fig. 2b). As confirmed by ISH, TLR2 
mRNA expression was largely confined to the basal layer of the 
epithelium, whereas in BE and EAC a more diffuse expression 
pattern throughout the biopsy was observed. 
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Immunostaining showed predominant expression of 
TLR2 in the basal keratinocytes in SQ, whereas in RE, TLR2 
expression was observed around the papillae high up in 
the epithelium due to papillary hyperplasia. In BE, TLR2 
expression was most prominent in superficial epithelial cells 
and deeper crypts, but was also observed in lamina propria 
cells. In EAC, diffuse TLR2 expression was observed (Fig. 
2c). 
The effect of TLR2 stimulation in BE epithelium cells
Upon short-term (24 hours) incubation with the 
TLR2 agonist Pam3CSK4 in BE epithelium cells (BAR-T), 
upregulation of TLR2 mRNA expression was observed 
(Fig. 3a). Additionally, Pam3CSK4 incubation resulted in 
a significant increase in IL8 mRNA expression and a dose-
dependent increase in IL8 secretion in BAR-T cells (Fig. 3b, 
c). These results illustrate that an inflammatory response is 
induced upon TLR2 activation in non-neoplastic BE cells. 
As expected, IL8 secretion was not increased in the negative 
control cells line HEK293, which do not express TLR2, 
following incubation with the TLR2 agonist (Fig. 3d). 
TLR2 activation in BE epithelium cells after long-term 
exposure to acid and bile salts
After 4 weeks of repeated exposure of BAR-T cells to acid 
and bile salts, using 200 µM bile salts mixture composed of 25% 
DCA, 45% GCA and 30% TCDCA at pH 4, in the presence or 
absence of the TLR2 agonist (12.5 ng/ml Pam3CSK4), RNA 
was isolated, cells were fixated for EM and culture medium 
was collected.
Increased IL8 mRNA expression and secretion was 
observed in BAR-T cells incubated with both acid and bile salts 
and the TLR2 agonist compared to control cells (Fig. 4a, b). 
The effect of short-term (24 hours) exposure to TLR2 agonist 
and acid and bile salts is shown in Supplemental Fig. 1. 
Morphological changes were evaluated using EM. An initial 
screening of the EM images evidenced few differences between 
experimental conditions. The BAR-T cells looked vital and no 
apoptotic changes were observed: no abnormal nuclear content, 
chromatin condensation or nucleolus segregation and no 
swelling of mitochondria and cellular shrinkage were observed 
(data not shown). Stereological methods revealed that a larger 
proportion of the cell volume consisted of vehicles from the 
endocytic pathway (early endosomes, multivesicular bodies 
and lysosomes together) in BAR-T cells incubated with both 
the TLR2 agonist and acid and bile salts compared to BAR-T 
cells incubated with the TLR2 agonist or acid and bile salts 
alone (Fig. 4c, d, e). Additionally, a larger proportion of the cell 
volume consisted of mitochondria in BAR-T cells incubated 
with both the TLR2 agonist and acid and bile salts compared to 
BAR-T cells incubated with acid and bile salts alone (p=0.02) 
(Fig. 4f). Volume densities of endoplasmic reticulum, Golgi 
Fig. 3. The effect of short-term TLR2 activation in BE epithelium cells. a) Q-RT-PCR showed that TLR2 mRNA 
expression was significantly increased in BAR-T cells incubated with Pam3CSK4 for 24 hours compared to control 
cells not incubated with Pam3CSK4. b) Q-RT-PCR showed that IL8 mRNA expression was significantly increased in 
BAR-T cells incubated with Pam3CSK4 for 24 hours compared to control cells. In addition, BAR-T cells incubated 
with TNFα also showed an increased IL8 expression. c) ELISA showed a dose-dependent increase in IL8 secretion 
in the cell culture supernatant of BAR-T cells upon 24 hours of Pam3CSK4 incubation. In positive control cells 
incubated with TNFα, IL8 secretion was also increased. d) In negative control cells HEK293, IL8 secretion was not 
increased upon Pam3CSK4 incubation. Experiments were performed 3 times in duplicate. Data were normalized to 
control samples not incubated with Pam3CSK4. In Q-RT-PCR experiments GAPDH and β-2-microglobulin were 
used for normalization. * p<0.05, ** p<0.01.
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Fig. 4. Morphological changes upon long-term TLR2 stimulation in BE epithelium cells. a) Q-RT-PCR showed that IL8 mRNA expression 
was significantly increased in BAR-T cells incubated with 12.5ng/ml of the TLR2 agonist Pam3CSK4, acid and bile salts mixture (200 µM; 
25% DCA, 45% GCA and 30% TCDCA at pH 4) and with both acid and bile salts mixture and Pam3CSK4 for 4 weeks compared to control 
cells. b) ELISA showed an increase in IL8 secretion in the cell culture supernatant of BAR-T cells incubated with 12.5ng/ml Pam3CSK4, acid 
and bile salts and both Pam3CSK4 and acid and bile salts for 4 weeks compared to control cells. c) In BAR-T cells incubated with Pam3CSK4 
and acid and bile salts, more and/or larger lysosomes and mitochondria were observed compared to BAR-T cells incubated with acid and bile 
salts and Pam3CSK4 alone. Representative EM images are demonstrated. In the bottom left panel some organelles have been coloured and 
the square lattice test system to measure volume densities is depicted. G=golgi complex, L=lysosome, M=mitochondrium (red), N=nucleus 
(purple), arrow=multivesicular body (blue), arrowhead=endoplasmic reticulum (yellow). d) A larger proportion of the cell volume consisted 
of lysosomes in BAR-T cells incubated with both the TLR2 agonist and acid and bile salts compared to cells incubated with acid and bile salts 
alone. e) A larger proportion of the cell volume consisted of compartments of the endocytic pathway (early endosomes, multivesicular bodies 
and lysosomes together) in BAR-T cells incubated with both the TLR2 agonist and acid and bile salts compared to cells incubated with acid 
and bile salts alone. f) A larger proportion of the cell volume consisted of mitochondria in BAR-T cells incubated with both the TLR2 agonist 
and acid and bile salts compared to cells incubated with acid and bile salts alone; a non-significant increase was observed compared to the 
TLR2 agonist alone and control BAR-T cells. Number of images analyzed: 15 per experimental condition. * p<0.05, ** p<0.01, ***p<0.001. 
complex, calveoli, filaments, cytoplasm and nucleus were 
not significantly different. The total volume of BAR-T cells, 
represented by the total number of counted points, was the 
same for the various experimental conditions (data not shown). 
Expression of factors involved in lysosomal function
Expression of lysosomal enzymes and factors involved in 
endocytosis and autophagy were determined upon incubation 
of BE cells with acid and bile salts in the presence or absence 
of the TLR2 agonist Pam3CSK4 for 4 weeks. Q-RT-PCR 
results indicated a significantly increased expression of the 
lysosomal enzymes Cathepsin B and C upon incubation 
with Pam3CSK4 in combination with acid and bile salts 
compared to BAR-T cells incubated with acid and bile salts 
or Pam3CSK4 alone (Fig. 5a, b). In addition, expression of 
LAMP-1 and M6PR, factors associated with endocytosis, 
was significantly increased in BAR-T cells incubated with 
acid, bile salts and Pam3CSK4 (Fig. 5c, d). This effect was 
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less evident when analyzing the expression of autophagy 
associated factor Rab7 and no difference in LC3 expression 
was observed (Fig. 5e, f). 
DISCUSSION
This study demonstrates the TLR2 expression in normal SQ, 
RE, BE and most prominent in EAC biopsies, in both immune 
and epithelial cells. Previous studies have shown the expression 
of TLR2 (and TLR1, TLR3 and TLR5) in SQ [29] and TE-1 
(and TLR3, TLR4 and TLR7) in an esophageal squamous cell 
carcinoma cell line [30]. Huhta et al. recently demonstrated a 
slight increase in TLR2 expression from SQ towards intestinal 
metaplasia, dysplasia and EAC [31]. These findings largely 
correspond to the results of the present study. Differential 
expression and signalling of TLRs have been demonstrated in 
various gastrointestinal diseases, resulting in host protection 
through the induction of immune responses and damage 
repair processes. In addition, simultaneous stimulation of 
carcinogenesis has been observed [18, 22, 32, 33].  
TLR2 is a pattern recognition receptor, which is activated 
by lipoproteins and peptidoglycans from gram positive bacteria 
and endogenous ligands released by stressed tissue [18]. 
The TLR2 agonist Pam3SCK4 used in the present study is a 
synthetic lipoprotein, which preserved most of the immune 
modulatory effects of its natural lipoproteins [23]. Previous 
studies have shown colonizing of gram-positive bacteria in 
the esophagus, which were predominantly present in SQ [34, 
35]. In RE and BE, a switch towards a more gram-negative 
microbiome has been observed [34-36]. In addition to 
microbial products, endogenous heat shock proteins and high 
mobility group box 1 protein have been found to be capable 
of enhancing TLR2 signalling through binding to bacterial 
lipopeptide [37]. These data suggest that both exogenous 
and endogenous ligands contribute to TLR2 signalling in the 
esophagus. Previous studies have shown that TLR2 plays a 
protective role in intestinal inflammation. TLR2 is upregulated 
in the inflamed intestine, protecting gut mucosa by maintaining 
the gap junction structure and intercellular communication 
between intestinal epithelial cells during acute damage [38]. A 
study by Lowe et al. demonstrated that TLR2 protects against 
tumor development in mice in a colitis-induced cancer model 
by maintaining the epithelial homeostasis and reducing the 
inflammation [8].
Fig. 5. Expression of factors involved in lysosomal function. Q-RT-PCR showed significantly increased Cathepsin B, C, LAMP-
1 and M6PR expression in BAR-T cells incubated with Pam3CSK4 in combination with acid and bile salts compared to cells 
incubated with acid and bile salts or Pam3CSK4 alone (a, b, c, d). Rab7 expression was increased in cells incubated with both 
Pam3CSK4 and acid and bile salts compared to cells incubated with Pam3CSK4 alone (e). No difference in LC3 expression 
was observed (f). Expression data were normalized to BAR-T cells incubated with acid and bile salts.  * p<0.05, ** p < 0.01. 
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IL8 expression and secretion, which were used as a read-
out for the induction of an inflammatory response, were 
increased following TLR2 stimulation in BE (BAR-T) cells. 
Interestingly, IL8 secretion had previously been found to be 
induced in esophageal squamous cell carcinoma cell lines 
(TE-1 and TE-7) upon TLR2 activation, which was not shown 
in SQ cells (primary squamous epithelium cells, EPC2 and 
EPC2-hTERT) [29, 39]. 
The effects of long-term TLR2 activation on morphological 
changes and the expression of factors involved in lysosomal 
function in BE epithelium cells exposed to acid and bile salts 
were studied. The lysosomal pathway consists of endocytosis, 
a process starting with early endosomes, represented by the 
cytoplasmic domain of cell membrane proteins, which is 
internalized into vesicles with ingested extracellular material 
[14]. M6PR is found on late endosomes, a subsequent 
compartment of the degradation pathway, and binds to 
lysosomal proteins emitting from the Golgi complex [12, 13]. 
M6PR is mutated or downregulated in various malignancies 
[17]. LAMP-1 is a transmembrane protein, highly enriched 
in both late endosomes and lysosomes [15]. Autophagy is 
responsible for the degradation of intercellular components, 
in which LC3 and Rab7 are involved [12]. Endosomes and 
autophagosomes either traffic to lysosomes and fuse with 
the lysosomal limiting membrane, comprising a degradation 
machinery constituted of catalytic enzymes, such as cathepsins, 
or endosomes are subject to a recycling process [14, 16]. In the 
present study, long-term TLR2 stimulation in acid and bile 
salts exposed BE (BAR-T) cells resulted in increased numbers 
and larger volumes of lysosomes, more mitochondria, and 
upregulated expression of the lysosomal enzymes Cathepsin B 
and C and endocytosis associated factors LAMP-1 and M6PR. 
This effect was not observed in BE epithelium cells incubated 
with acid and bile salts or the TLR2 agonist alone. Only a 
change in Rab7 expression was observed in cells incubated with 
acid, bile salts and TLR2 agonist compared to cells incubated 
with TLR2 agonist alone. No difference in the expression of 
LC3 was observed. Our results may suggest that induction of 
lysosomal activity and endocytosis upon TLR2 signalling in 
combination with acid and bile salts exposure may also occur 
in BE. To our knowledge, the association between TLR2 
signalling and lysosomal function in the esophagus has not 
been reported before.
TLR2 signalling was previously found to facilitate 
autophagy dependent nuclear factor–κB (NF-κB) activation 
in bone marrow-derived macrophages [19]. The lysosomal 
compartment plays an important role in tissue homeostasis and 
cellular function, including processing exogenous material and 
recycling damaged organelles and molecules [12, 13, 16, 40]. 
The suggested induction of lysosomal activity and endocytosis 
following TLR2 signalling in the presence of acid and bile salts 
may increase degradation of waste products and elimination 
of luminal danger signals in BE. Accordingly, effective 
lysosomal function is crucial in malignancies to facilitate 
survival and rapid growth of cancer cells [16]. Previous 
studies have shown that changes in lysosomal function are 
involved in carcinogenesis. Cathepsin B overexpression has 
been demonstrated to attribute to the invasive and metastatic 
potential of malignancies, e.g. in pancreatic and prostate cancer 
[41, 42]. In adenocarcinomas of the gastro-esophageal junction, 
increased Cathepsin B activity was found to correlate with 
lymph node involvement [6]. 
The strength of this study is the incorporation of a long term 
cell culture experiment for a period up to four weeks and the 
use of EM to assess morphological changes after stimulation 
with the TLR2 agonist in combination with acid and bile salts 
in a BE cell line. However, there are also some limitations in 
this study. We determined the effect of TLR2 signalling in 
combination with acid and bile salts incubation on mRNA 
expression of factors involved in the lysosomal pathway ex 
vivo. Future experiments should focus on functional activity 
assays or protein expression analyses in vivo. Furthermore, 
this study did not demonstrate an actual protective effect or 
‘healthier’ phenotype as a result of the induction of lysosomal 
activity and endocytosis upon TLR2 stimulation in acid 
and bile salts exposed BE epithelium cells. In the future, the 
pathophysiological association between TLR2 and lysosomal 
function and the effect of the induction of lysosomal activity 
and endocytosis accompanying TLR2 activation in the 
presence of acid and bile salts in BE and the effect on cellular 
phenotype needs to be further elucidated, using additional cell 
lines, organoids [43] and/or animal models. 
CONCLUSION
TLR2 signalling in acid and bile salts exposed BE 
epithelium cells resulted in an increased expression of 
lysosomal enzymes and accompanying factors involved in 
endocytosis. This observation, together with an increased 
number of mitochondria and extended numbers and larger 
volumes of lysosomes, may suggest the induction of lysosomal 
activity and endocytosis following TLR2 signalling in the 
presence of acid and bile salts. Interestingly, these results 
support a possible role of the innate immune system in BE, 
in that TLR2 activation in BE (during reflux episodes) may 
increase clearing of waste accumulations, contributing to 
cellular homeostasis and defence, and thus might be involved 
in the protection against EAC development in BE. 
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Figure 1. Short-term stimulation of BAR-T cells with the TLR2 agonist and acid and 
bile salts 
a) Short-term (24 hours) exposure to the TLR2 agonist Pam3CSK4 and acid and bile salts 
mixture resulted in increased interleukin (IL) 8 mRNA expression in BAR-T cells 
incubated with 12.5ng/ml Pam3CSK4, with acid and bile salts (200 µM; 25% DCA, 45% 
GCA and 30% TCDCA at pH 4) and with both acid and bile salts mixture and Pam3CSK4 
compared to control BAR-T cells, as demonstrated by Q-RT-PCR.  
b) ELISA showed an increase in IL8 secretion in the cell culture supernatant of BAR-T cells 
incubated with 12.5ng/ml Pam3CSK4, acid and bile salts and both Pam3CSK4 and acid 
and bile salts for 4 weeks compared to control cells.  
 
A B C 
Semnalizarea prin Receptorul Toll-like 2 (TLR-2) și mecanismul 
lizozomal în esofagul Barrett 
ABSTRACT / REZUMAT
Premize și Scop: Inflamația joacă un rol important în dezvoltarea adenocarcinomului   esofagian și a leziunii sale metaplazice precursoare, 
esofagul Barrett. Semnalizarea prin receptorii Toll-like 2  (TLR2) și funcția lizozomală au fost considerate a avea legătură cu  carcinogeneza 
asociată inflamației. Am examinat pe o linie celulară de esofag Barrett expresia TLR2 în esofag și efectul activării pe termen lung a TLR2 
asupra modificărilor morfologice și expresiei factorilor implicați în funcția esofagului.  
Metodă: Expresia TLR2 în biopsiile din esofagul scuamos normal, esofagita de reflux, esofagul Barrett și adnocarcinomul esofagian a fost 
evaluată prin Q-RT-PCR, hibridizare in situ și imunohistochimie. Celulele epiteliale ale esofagului Barrett (BAR-T) au fost incubate cu acizi 
și săruri biliare în prezența sau absența agonistului Pam3CSK4 al TLR2 pentru o perioadă de până la 4 săptămîni. Modificările morfologice 
au fost evaluate prin electronomicroscopie, iar Q-RT-PCR a fost utilizată pentru a determina expresia enzimelor lizozomale (catepsina B și 
C) și a factorilor implicați în endocitoză (LAMP-1 și M6PR) și autofagie (LC3 și Rab7). 
Rezultate: Expresia TLR2 a fost prezentă în esofagul scuamos normal, esofagita de reflux și esofagul Barrett, dar a fost mai proeminentă în 
adenocarcinomul esofagian.   Activarea pe termen lung a TLR2 în celulele BAR-T expuse la acizi și săruri biliare a condus la lizozomi mai 
mulți și mai mari, mitocondrii mai multe și o expresie crescută a LAMP-1, M6PR, catepsinei B și C în comparație cu celulele BAR-T incubate 
cu acizi și săruri biliare dar fără agonistul TLR2. Factorii asociați cu expresia autofagiei (LC3 și Rab7) au rămas în general nemodificați.  
Concluzie: Activarea TLR2 în celulele epiteliale ale esofagului Barrett expus la acizi și săruri biliare a fost urmată de creșterea numărului de 
mitocondrii și lizozomi și de o expresie crescută a enzimelor lizozomale și a factorilor implicați în endocitoză.   
